Chemestmed reports remarkable neuroprotective effects of our unique RNA m6A methyltransferase METTL3/METTL14/WTAP activators
26.07.2023
In a preprint deposited in Cold Spring Harbor Laboratory server bioRxiv, Chemestmed reports in collaboration with the Universities of Tartu and Helsinki remarkable neuroprotective effects of our unique RNA m6A methyltransferase METTL3/METTL14/WTAP activators in vitro and in vivo PD animal model.
“Small molecule activation of m6A mRNA methylation as a novel approach for neuroprotection”